Approved Study Database

Ref. No. Scientific Title Principal investigator
2008.533 Reading difficulties in Chinese (L1) and English (L2): Comorbidity and congitive and perceptual correlates in Hong Kong Chinese second graders Professor McBride Catherine Alexandra
2010.565 Reading difficulties in Chinese (L1) and English (L2): Co-occurrence and cognitive and perceptual correlates in Hong Kong children Professor McBride-Chang Catherine Alexandra
2013.456 Reading Development in Chinese and in English: Genetic and Neuroscience Correlates Prof. MCBRIDE-CHANG Catherine
2020.073 Readiness of Health Care Workers Tackling Epidemic of Novel Coronavirus (COVID-19) in Hong Kong Prof. WONG Eliza Lai Yi
黃麗儀
2013.618 Reactive myocardial fibrosis related mechanical dyssynchrony in patients with hypertension – An early marker of myocardial involvement? Prof. SHANG Qing
2024.438 Re-Defining Standard of Care – Heart Failure and Fluid Assessment Dr. KAM Kevin Ka Ho
2008.192 RCT of Self-Regulated Constraint-Induced Therapy for Functional Regain for People with Sub-Acute Stroke Ms LEUNG LAI FONG TERESA
2021.169 RCT of magnesium cream vs analgesic balm to control bunion pain Dr. LING Ka Kin Samuel
凌家健
2020.448 Rationale and Design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): A Randomized, Open-label study Prof. YAN Bryan Ping Yen
甄秉言教授
2024.152 Rationale and design of Dabigatran for Mitral Stenosis Atrial Fibrillation Trial Prof. YAN Bryan Ping Yen
甄秉言
2018.635 Rational interlocutor modelling in language comprehension and production Dr. CAI Zhenguang
蔡振光
2005.384 Rate and Determinants of Conversion from Mild Cognitive Impairment (MCI) to Dementia among Chinese HO Wency
2015.098 Rare Disease Registry Program Dr. HUI Joannie
2009.416 Rapid Triage and Early Diagnosis of Acute Myocardial Infarction using CardioDetect_ H-FABP rapid test in Patients with Acute Chest Pain: A Randomised, Controlled Trial Professor Rainer Timothy H
2009.049 Rapid quantification and characterization of the broad spectrum of microbial population involved in preterm labour Prof CHIM Stephen Siu-chung
2011.073 Rapid identification of bacterial genes associated with antibiotic resistance by quantitative polymeras chain reaction Prof. LAM Hugh Simon Hung San
2003.358 Rapid Detection of Food-Borne Pathoges in Clinical Specimens, Foods and Environmental Samples LING Mei Lun Julia
2012.170 Rapid detection for multiple respiratory pathogens in febrile children with cancers in a children's cancer center Prof. Leung Ting Fan
2020.117 Rapid and Sensitive Detection of Tumor-Derived Exosomal MicroRNAs Using Gapped Bilayer Graphene Field-Effect Biosensors Prof. GAO Zhaoli
2023.401 RANKL Inhibition to Combat Sarcopenia in Hip Fracture Patients: A Pragmatic, Randomized Double-blind, Active-Controlled Trial Prof. WONG Ronald Man Yeung
2022.555 RANK-ligand Inhibition to Combat Sarcopenia with Underlying Osteoporosis: A Randomized, Double-blind, Double-dummy, Active-Controlled Trial Prof. WONG Ronald Man Yeung
2021.484 Randomized, Open-label, Phase 3 Study of Acapatamab vs Standard of Care in Metastatic Castration-resistant Prostate Cancer (CAPTIVATE) Prof. NG Chi Fai
吳志輝
2005.189 Randomized, Open-Label, Comparative Study To Evaluate Early Viral Load Reductions and Exploratory Viral Kinetics Following Administration of Entecavir or Adefovir in Nucleoside-Na_ve Adults with Chronic Hepatitis B Infection Dr. Leung Wai Yee Nancy
2008.249 Randomized, Open Label, Phase III Trial of CP-751, 871 in Combination with Paclitaxel and Carboplatin versus Paclitaxel and Carboplatin in Patients with Non-Small Cell Lung Cancer Prof MOK Tony, S.K.
2006.013 Randomized, Multinational, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20mg OD for Reducing the Risk of Major Cardiovascular Events in Abdominally Obese Patients with Clustering Risk Factors Dr. Chow C.C. Francis
2014.256 RANDOMIZED, MULTICENTER, PHASE III, OPEN LABEL STUDY OF ALECTINIB VERSUS CRIZOTINIB IN TREATMENT NAÏVE ANAPLASTIC LYMPHOMA KINASE-POSITIVE ADVANCED NON–SMALL-CELL LUNG CANCER Prof. MOK Tony Shu Kam
2015.361 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Ramucirumab and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (AFP) Following First-Line Therapy With Sorafenib Dr. CHAN Stephen Lam
陳林
2013.584 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE, THE VERTIS CV STUDY Dr. TSANG Chiu Chi
2013.588 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE, THE VERTIS CV STUDY Dr. LUK Andrea On Yan
2013.582 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE, THE VERTIS CV STUDY Prof. LEE Alex Pui Wai
2013.606 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE Dr. Kung Kenny
2016.442 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE, THE VERTIS CV STUDY Prof. MA Ronald Ching Wan
馬青雲
2014.334 Randomized, double-blind, placebo-controlled, multicenter study comparing Ciprofloxacin DPI 32.5 mg BID intermittently administered for 28 days on / 28 days off or 14 days on / 14 days off versus placebo to evaluate the time to first pulmonary exacerbation and frequency of exacerbations in subjects with non-cystic fibrosis bronchiectasis Prof. HUI David Shu Cheong
2007.495 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Repeated Dose Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE5026 (10, 20 and 60 mg) Given Once Daily as Subcutaneous Injections in Healthy Young Male Chinese Subjects MD Tomlinson Brian
2014.515 Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate (110 mg or 150 mg, oral b.i.d.) versus acetylsalicylic acid (100 mg oral q.d.) in patients with Embolic Stroke of Undetermined Source (RESPECT ESUS) Dr. SOO Yannie O.Y.
2006.318 Randomized, Double-Blind Trial Comparing the Effects of A 3-Month Clopidogrel Regimen, Combined with ASA during the First Month, Versus ASA Alone for the Acute Treatment of Patients with TIA or Minor Stroke CASTIA-Clopidogrel in Acute Stroke and TIA Dr. Leung Wai Hong Thomas
2021.038 Randomized-Controlled Trial of Trazodone on Reducing Plasma sST2 Level and Neurodegeneration Progression in Patients with Amnestic Mild Cognitive Impairment and Obstructive Sleep Apnea Prof. KWOK Timothy C.Y.
2011.583 Randomized- controlled study of the effectiveness of a new psychiatric specialist outpatient service model - the Multidisciplinary Assessment and Psychosocial intervention Program (MAP) vs standard psychiatric out-patient care. Dr. Lin Wei
2006.256 Randomized Trial to Evaluate the Therapeutic Gain by Changing the Chemoradiotherapy from Concurrent-Adjuvant to Induction-Concurrent Sequence, and the Radiotherapy from Conventional to Accelerated Fractionation for Advanced Nasopharyngeal Carcinoma Prof. CHAN Anthony
2012.582 Randomized trial on low-molecular weight heparin infusion as anticogulation for intermittent haemodialysis Dr. WONG Siu Man
2013.201 Randomized trial on intraveous antibiotics with adjunctive lavage for severe peritoneal-dialysis related peritonitis Dr. WONG Siu Man
2021.226 Randomized trial on associated liver partition and portal vein ligation with staged hepatectomy (ALPPS) versus portal vein embolization (PVE) for insufficient future liver remnant in patients with hepatocellular carcinoma undergoing major hepatectomy (ALPPS – PVE trial) Prof. NG Kelvin Kwok Chai
吳國際
2023.075 Randomized trial on Acutely Dissected Aorta Repair with Hemiarch replacement with or without stent implantation (RADAR trial) Prof WONG Randolph Hung Leung
黃鴻亮
2006.084 Randomized Trial of Intragastric Balloon and Pharmacotherapy for Non-Morbid Obesity MUI Lik Man Wilfred
1995.526 Randomized Trial of High-Dose Epirubicin and Cyclophamide x 3 Supported by Peripheral Blood Projector Cells Versus Anthracycline and Cyclophosphamide x 4 Followed by Cyclophosphamide, Methotrexate & 5- Fluorouracil as Adjuvant Treatment for High Risk Operable Stage II and Stage III Breast Cancer in Premenopausal and Young Postmenopausal (<65 yrs) Patients Prof. YEO Winnie
2005.313 Randomized Trial Comparing Terazosin 5mg Daily and Doxazosin GITS 4mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up Dr. Cheng Chi Wai
2022.379 Randomized trial comparing one-stage robotic approach versus two-stage endo-laparoscopic approach for difficult choledocholithiasis (REAL trial) Prof. LAU James Yun Wong
2006.300 Randomized Trial Comparing Alfuzosin GITS 10mg Daily With Placebo With Long Term Follow Up After Successful Trial Without Catheter in Acute Urinary Retention Dr. Ng Chi Fai
2005.332 Randomized Trial Comparing Alfuzosin GITS 10mg Daily With Placebo For Trial Without Catheter In Acute Urinary Retention With Long Term Follow UP Dr. Cheng Chi Wai
2007.194 Randomized Trial Comparing A Novel Physical Antimicrobial Dressing Aerosal (Jieyoushen) With Placebo in Prevention of Catheter Associated Urinary Tract Infection in Chinese Patients with Urethral Catheter Secondary to Acute Retention of Urine Prof.. Ng Chi Fai

Page 58 of 254.